A tumor paint developed by researchers at Seattle Children?s Hospital Research Institute and Fred Hutchinson Cancer Research Center will help surgeons see where a tumor begins and ends more precisely by illuminating the cancerous cells.
The GMC Panel will inquire into allegations of serious professional misconduct by Dr Wakefield, Professor Walker-Smith and Professor Murch, in relation to the conduct of a research study involving young children from 1996-98.
With the arrival of warmer weather, many people are spending more and more time in the sun. However, basking in the sun, especially without protecting your skin can lead to wrinkles, premature aging and, worst of all, skin cancer.
Dent Fresh U.S.A., Inc, Miami, Florida, is initiating a nationwide recall in accordance with the U.S. Food and Drug Administration (FDA) of the toothpaste made in China involving all : DentFresh Fluoride Mint Toothpaste 9 Oz (255g).
A diagnosis of type I diabetes means a life sentence of medical follow-up. While treatments have become simpler and less restrictive in recent years, they are still a burden, especially for young patients.
Summer is a challenging time for parents of teens and pre-teens. Gone are the daily structure and routine of the school year–giving teens more time to pursue other interests, or activities that may get them into trouble.
Using innovative physics, researchers have proposed a system that may one day bring proton therapy, a state-of-the-art cancer treatment method currently available only at a handful of centers, to radiation treatment centers and cancer patients everywhere.
Listed Australian biotech company Acrux (ASX: ACR) has taken a significant step forward towards becoming a world leader in the simple and effective delivery of male testosterone replacement therapy, following the success of a clinical trial with its innovative testosterone under-arm lotion.
A top panel of experts will face questions of public and scientific concern on stem cell research, during an international conference being held at the University of Manchester this week.
New research suggests that an eyedrop used to diagnose a rare syndrome in infants can cause severe lethargy lasting up to 10 hours and requiring hospital admission and oxygen administration.